Chapter/Section Purchase

Leave This Empty:

Global Neglected Tropical Disease (NTD) Treatment Market Research Report 2022

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Neglected Tropical Disease (NTD) Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Disease (NTD) Treatment Market Perspective (2017-2028)
2.2 Neglected Tropical Disease (NTD) Treatment Growth Trends by Region
2.2.1 Neglected Tropical Disease (NTD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neglected Tropical Disease (NTD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Neglected Tropical Disease (NTD) Treatment Market Dynamics
2.3.1 Neglected Tropical Disease (NTD) Treatment Industry Trends
2.3.2 Neglected Tropical Disease (NTD) Treatment Market Drivers
2.3.3 Neglected Tropical Disease (NTD) Treatment Market Challenges
2.3.4 Neglected Tropical Disease (NTD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue
3.1.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Neglected Tropical Disease (NTD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Disease (NTD) Treatment Revenue
3.4 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio
3.4.1 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Disease (NTD) Treatment Revenue in 2021
3.5 Neglected Tropical Disease (NTD) Treatment Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Disease (NTD) Treatment Product Solution and Service
3.7 Date of Enter into Neglected Tropical Disease (NTD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Type
4.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2023-2028)
5 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Application
5.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neglected Tropical Disease (NTD) Treatment Market Size (2017-2028)
6.2 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2017-2022)
6.3 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Neglected Tropical Disease (NTD) Treatment Market Size (2017-2028)
7.2 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2017-2022)
7.3 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Neglected Tropical Disease (NTD) Treatment Market Size (2017-2028)
9.2 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2017-2022)
9.3 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Neglected Tropical Disease (NTD) Treatment Introduction
11.2.4 Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.2.5 Bayer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Disease (NTD) Treatment Introduction
11.4.4 Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neglected Tropical Disease (NTD) Treatment Introduction
11.5.4 Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Eisai
11.6.1 Eisai Company Detail
11.6.2 Eisai Business Overview
11.6.3 Eisai Neglected Tropical Disease (NTD) Treatment Introduction
11.6.4 Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.6.5 Eisai Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Neglected Tropical Disease (NTD) Treatment Introduction
11.7.4 Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.7.5 Sanofi Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Detail
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Introduction
11.8.4 Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.8.5 Astellas Pharma Recent Development
11.9 Takeda Pharmaceutical Company
11.9.1 Takeda Pharmaceutical Company Company Detail
11.9.2 Takeda Pharmaceutical Company Business Overview
11.9.3 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Introduction
11.9.4 Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.9.5 Takeda Pharmaceutical Company Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Introduction
11.10.4 Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2017-2022)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details